Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB
News | Drug-Eluting Balloons
Boston Scientific AGENT Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

October 30, 2023 β€” Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT ...

Home October 30, 2023
Home
Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
News | Stents Bioresorbable
Late-breaking Data Show Esprit BTK Drug-eluting Resorbable Scaffold Reduces Chronic Limb-threatening Ischemia Progression Compared to the Standard of Care

October 30, 2023 β€” Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK ...

Home October 30, 2023
Home
Key findings demonstrate patients with aortic stenosis have substantial untreated mortality risk across all levels of aortic stenosis severity, but aortic valve replacement rates remain low even for patients with severe aortic stenosis
News | Endovascular Aortic Repair
Philippe GΓ©nΓ©reux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at TCT23

October 30, 2023 β€” -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...

Home October 30, 2023
Home
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference
News | Cath Lab
iFR and FFR are Equally Safe to Diagnose and Treat Heart Disease According to Largest-ever Analysis of New Real-world, Long-term Data

October 26, 2023 β€” Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US
News | Structural Heart
Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

October 26, 2023 β€” Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

Home October 26, 2023
Home
New clinical data support use of lesion-specific FFRCT for diagnosis and treatment of patients with coronary artery disease
News | Computed Tomography (CT)
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights

October 26, 2023 β€” HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
DAIC TCT23 STS Statement Logo
News | TCT
Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

October 26, 2023 β€” The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

Home October 26, 2023
Home
DAIC TCT SCAI image
News | TCT
New Study Reveals Inequities in Access to Mechanical Circulatory Support in US Patients with Cardiogenic Shock

October 26, 2023 β€” A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...

Home October 25, 2023
Home
DAIC TCT 2023 Elixir image
News | TCT
Six-Month Clinical Data from DESyne BDS Plus Randomized Controlled Trial (RCT) Presented at TCT 2023 Shines Spotlight on Safety, Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy

October 25, 2023 β€” Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

Home October 25, 2023
Home
TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial
News | TCT
Medtronic Evolut TAVR Platform Outperforms Surgery with Sustained Valve Performance for Low-risk Patients at Four Years

October 25, 2023 β€” Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut ...

Home October 25, 2023
Home
Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years
News | Cardiovascular Surgery
Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve

October 25, 2023 β€” Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...

Home October 25, 2023
Home
Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices
News | Pulmonary Embolism
REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism

October 25, 2023 β€” Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT) ...

Home October 25, 2023
Home
Clinical research validates utility of IVL in complex nodular and eccentric calcium
News | Cath Lab
New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

October 25, 2023 β€” Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
Clinical research validates utility of IVL in complex nodular and eccentric calcium
News | Left Atrial Appendage (LAA) Occluders
ConcertAI's TeraRecon Showcases New Clinical and AI Solutions Designed to Enhance Treatment Planning for Structural Heart Patients at TCT 2023

October 25, 2023 β€” ConcertAI's TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for ...

Home October 25, 2023
Home
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference
News | Left Atrial Appendage (LAA) Occluders
Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

October 25, 2023 β€” Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing ...

Home October 25, 2023
Home
Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now